» Articles » PMID: 17301065

Copy Number Variant in the Candidate Tumor Suppressor Gene MTUS1 and Familial Breast Cancer Risk

Overview
Journal Carcinogenesis
Specialty Oncology
Date 2007 Feb 16
PMID 17301065
Citations 39
Authors
Affiliations
Soon will be listed here.
Abstract

Copy number variants (CNVs), insertions, deletions and duplications, contribute considerably to human genetic variation and disease development. A recent study has characterized 100 CNVs including a deletion in the mitochondrial tumor suppressor gene 1 (MTUS1) lacking the coding exon 4. MTUS1 maps to chromosome 8p, a region frequently deleted and associated with disease progression in human cancers, including breast cancer (BC). To investigate the effect of the MTUS1 CNV on familial BC risk, we analyzed 593 BC patients and 732 control individuals using a case-control study design. We found a significant association of the deletion variant with a decreased risk for both familial and high-risk familial BC (odds ratio (OR) = 0.58, 95% confidence interval (CI) = 0.37-0.90, P = 0.01 and OR = 0.41, 95% CI = 0.23-0.74, P = 0.003), supporting its role in human cancer. To our knowledge, the present study is the first to determine the impact of a CNV in a tumor suppressor gene on cancer risk.

Citing Articles

Copy number variation heterogeneity reveals biological inconsistency in hierarchical cancer classifications.

Yang Z, Carrio-Cordo P, Baudis M Mol Cytogenet. 2024; 17(1):26.

PMID: 39506842 PMC: 11542350. DOI: 10.1186/s13039-024-00692-2.


Four centrosome-related genes to predict the prognosis and drug sensitivity of patients with colon cancer.

Wang H, Diao Y, Tan P, Liang H World J Gastrointest Oncol. 2024; 16(5):1908-1924.

PMID: 38764831 PMC: 11099447. DOI: 10.4251/wjgo.v16.i5.1908.


A novel anoikis-related gene signature identifies LYPD1 as a novel therapy target for bladder cancer.

Song Z, Gui S, Xiao S, Rao X, Cong N, Deng H Sci Rep. 2024; 14(1):3198.

PMID: 38332160 PMC: 10853254. DOI: 10.1038/s41598-024-53272-0.


Exosome-Associated Gene Signature for Predicting the Prognosis of Ovarian Cancer Patients.

Zhu Z, Geng R, Zhang Y, Liu J, Bai J J Immunol Res. 2023; 2023:8727884.

PMID: 36726489 PMC: 9886487. DOI: 10.1155/2023/8727884.


A new ferroptosis-related genetic mutation risk model predicts the prognosis of skin cutaneous melanoma.

He J, Huang W, Li X, Wang J, Nie Y, Li G Front Genet. 2023; 13:988909.

PMID: 36685905 PMC: 9849373. DOI: 10.3389/fgene.2022.988909.